|
|
| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Drug Abuse Panel 8, with Confirmation, Serum and Volatiles, Blood
Test Code31678
CPT Codes
80307
Preferred Specimen
10 mL whole blood collected in a sodium fluoride or sodium fluoride/potassium oxalate (gray-top) tube
Minimum Volume
5 mL
Other Acceptable Specimens
Plasma collected in: Sodium fluoride or sodium fluoride/potassium oxalate (gray-top) tube • Frozen serum collected in a red-top tube (no gel)
Instructions
Collect sample using alcohol free skin preparation.
Optional: Whole blood for Volatiles analysis, only - Sodium Fluoride (unopened Gray-top) tube
Optional: Whole blood for Volatiles analysis, only - Sodium Fluoride (unopened Gray-top) tube
Transport Temperature
Whole blood and plasma: Refrigerated (cold packs)
Serum: Frozen
Serum: Frozen
Specimen Stability
Whole blood and plasma
Room temperature: 24 hours
Refrigerated: 7 days
Frozen: 30 days
Serum
Room temperature: Unacceptable
Refrigerated: Unacceptable
Frozen: 30 days
Room temperature: 24 hours
Refrigerated: 7 days
Frozen: 30 days
Serum
Room temperature: Unacceptable
Refrigerated: Unacceptable
Frozen: 30 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Serum separator tube (SST)
Methodology
Immunoassay • Chromatography/Mass Spectrometry
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Monday-Sunday Morning Report available: Next Day
Reference Range
See Laboratory Report
Clinical Significance
The serum or plasma concentration of a drug is measured as a guide to individuation of therapy. Additionally, the problem of noncompliance with prescribed medications during continuing therapy, particularly in the pain management field, is an elusive cause of therapeutic failure.
